Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001827506-25-000050
Filing Date
2025-04-21
Accepted
2025-04-21 16:12:16
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-21

Document Format Files

Seq Description Document Type Size
1 ARS trml12312024ars.pdf ARS 19905595
  Complete submission text file 0001827506-25-000050.txt   27420574
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40384 | Film No.: 25853273
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)